4.4 Review

Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis

Journal

CELL AND TISSUE RESEARCH
Volume 335, Issue 1, Pages 249-259

Publisher

SPRINGER
DOI: 10.1007/s00441-008-0682-9

Keywords

Src family kinases; Inhibitors; Tumor progression; Metastasis; Inflammation

Categories

Funding

  1. NIH [U54 CA090810, P20 CA101936, T32 CA 09599]
  2. NATIONAL CANCER INSTITUTE [P20CA101936, R01CA065527, T32CA009599, U54CA090810, P30CA016672] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Src family kinases (SFKs) are signaling enzymes that have long been recognized to regulate critical cellular processes such as proliferation, survival, migration, and metastasis. Recently, considerable work has elucidated mechanisms by which SFKs regulate normal and pathologic processes in vascular biology, including endothelial cell proliferation and permeability. Further, when inappropriately activated, SFKs promote pathologic inflammatory processes and tumor metastasis, in part through their effects on the regulation of endothelial monolayer permeability. In this review, we discuss the roles of aberrantly activated SFKs in mediating endothelial permeability in the context of inflammatory states and tumor cell metastasis. We further summarize recent efforts to translate Src-specific inhibitors into therapy for systemic inflammatory conditions and numerous solid organ cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available